ABT vs ECL
Abbott Laboratories (ABT) versus Ecolab Inc (ECL) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Not investment advice. Open the ABT and ECL stock pages for the full models.
Not investment advice.